Aalst Pharma
0444.748.067 · rovalta.com · 23/09/2026
ACTIVE
Aalst Pharma (SRL)
Financial year 2025 · closed on 31/12/2025
Net result
54 k €
+18.8% YoY
Gross margin
170,6 k €
+132.1% YoY
Equity
74,8 k €
-66.1% YoY
Workforce
1,4 ETP
+133.3% YoY
Overview
What does Aalst Pharma do?
Aalst Pharma is a Private limited company incorporated in 1991. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Aalst. It employs on average 1,4 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0444.748.067
Incorporation
19/07/1991
Legal form
Private limited company
Registered office
Gentse steenweg 49
9300 Aalst · FlandreSee on map
9300 Aalst · FlandreSee on map
Contributed capital
18 592,01 €
Latest accounts
31/12/2025
Average workforce
1,4 ETP
Activities (NACE)
Joint committees (1)
- 313
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 18 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||||||||||
| Gross margin | 170,6 k € | +132% | 73,5 k € | -58.9% | 178,8 k € | +7.3% | 166,6 k € | +22.2% | 136,4 k € | +73.3% | 78,7 k € | -13.5% | 91 k € | -4.0% | 94,8 k € | +25.3% | 75,7 k € | -22.7% | 97,9 k € | -5.7% | 103,8 k € | +22.7% | 84,5 k € | +36.1% | 62,1 k € | -30.9% | 89,8 k € | +5.3% | 85,3 k € | +292% | -44,4 k € | -785% | 6,5 k € | -72.2% | 23,3 k € |
| EBITDA | 86,3 k € | +78.3% | 48,4 k € | -69.8% | 160,6 k € | +9.7% | 146,4 k € | +23.7% | 118,3 k € | +89.0% | 62,6 k € | -14.1% | 72,9 k € | -3.8% | 75,8 k € | +29.3% | 58,6 k € | -27.4% | 80,7 k € | -7.3% | 87 k € | +24.0% | 70,2 k € | +7.5% | 65,3 k € | -26.8% | 89,2 k € | +6.1% | 84 k € | +289% | -44,4 k € | -785% | 6,5 k € | -72.2% | 23,3 k € |
| Operating result | 64,7 k € | +50.7% | 43 k € | -72.3% | 155 k € | +8.8% | 142,4 k € | +28.5% | 110,8 k € | +221% | 34,5 k € | -17.4% | 41,8 k € | -15.6% | 49,5 k € | +45.9% | 34 k € | -39.6% | 56,2 k € | -11.8% | 63,7 k € | +31.0% | 48,6 k € | +6.6% | 45,6 k € | -34.9% | 70 k € | -2.5% | 71,8 k € | +248% | -48,5 k € | -455% | -8,8 k € | -235% | 6,5 k € |
| Net result | 54 k € | +18.8% | 45,5 k € | -70.7% | 155,4 k € | +8.2% | 143,6 k € | +28.6% | 111,7 k € | +194% | 37,9 k € | -11.7% | 43 k € | -17.0% | 51,8 k € | +45.5% | 35,6 k € | -36.7% | 56,2 k € | -9.7% | 62,2 k € | +28.6% | 48,4 k € | -34.2% | 73,5 k € | +14.0% | 64,5 k € | -4.8% | 67,7 k € | +232% | -51,5 k € | -87.6% | -27,4 k € | -487% | 7,1 k € |
| Balance sheet | |||||||||||||||||||||||||||||||||||
| Equity | 74,8 k € | -66.1% | 220,8 k € | +0.2% | 220,3 k € | +0.1% | 220,1 k € | +0.1% | 219,9 k € | +0.1% | 219,7 k € | +0.0% | 219,6 k € | +0.1% | 219,4 k € | +0.1% | 219,2 k € | +1.2% | 216,6 k € | +2.5% | 211,4 k € | +3.5% | 204,2 k € | +4.3% | 195,8 k € | +26.5% | 154,8 k € | +16.1% | 133,2 k € | +26.3% | 105,5 k € | -32.8% | 157 k € | -14.9% | 184,4 k € |
| Total assets | 780,6 k € | +118% | 358,8 k € | -15.9% | 426,5 k € | -13.4% | 492,6 k € | +6.7% | 461,5 k € | +39.9% | 329,8 k € | +2.6% | 321,4 k € | -6.9% | 345,2 k € | +6.7% | 323,4 k € | -2.2% | 330,5 k € | -8.0% | 359,1 k € | -3.7% | 372,7 k € | -3.7% | 387,2 k € | -5.9% | 411,4 k € | +27.1% | 323,8 k € | +159% | 124,8 k € | -33.2% | 186,7 k € | -15.4% | 220,7 k € |
| Cash | 21,7 k € | -69.3% | 70,9 k € | -72.5% | 258,1 k € | +1.3% | 254,9 k € | -16.2% | 304 k € | +218% | 95,5 k € | +35.8% | 70,3 k € | -27.3% | 96,8 k € | +40.6% | 68,9 k € | +18.0% | 58,4 k € | -37.3% | 93,1 k € | -1.5% | 94,5 k € | -14.0% | 109,9 k € | -21.7% | 140,3 k € | +20.1% | 116,8 k € | +159% | 45,1 k € | +3.3% | 43,7 k € | -41.8% | 75,1 k € |
| Debts | 703,1 k € | +422% | 134,7 k € | -34.7% | 206,2 k € | -24.0% | 271,5 k € | +13.5% | 239,2 k € | +122% | 107,8 k € | +7.5% | 100,3 k € | -19.5% | 124,6 k € | +21.0% | 103 k € | -8.6% | 112,7 k € | -23.0% | 146,4 k € | -12.4% | 167,2 k € | -12.0% | 189,9 k € | -23.7% | 249,1 k € | +35.5% | 183,8 k € | +1183% | 14,3 k € | -51.9% | 29,8 k € | -17.9% | 36,3 k € |
| Other | |||||||||||||||||||||||||||||||||||
| Workforce | 1,4 ETP | +133% | 0,6 ETP | +20.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | – | – | – | – | – | – | ||||||
Estimate
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 9 ended
Active mandates
Active
Pieter Vermeersch
ActiveFinancials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/08/2026 | 11/07/2025 | 28/05/2024 | 19/07/2023 | 19/05/2022 | 31/08/2021 |
| General meeting | 11/05/2026 | 23/06/2025 | 13/05/2024 | 08/05/2023 | 09/05/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 11/05/2026 | 13/08/2026 | Dutch | |
| Abridged model | 31/12/2024 | 23/06/2025 | 11/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 13/05/2024 | 28/05/2024 | Dutch | |
| Abridged model | 31/12/2022 | 08/05/2023 | 19/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 09/05/2022 | 19/05/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 31/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 10/05/2020 | 04/06/2020 | Dutch | |
| Abridged model | 31/12/2018 | 13/05/2019 | 17/05/2019 | Dutch | |
| Abridged model | 31/12/2017 | 14/05/2018 | 31/05/2018 | Dutch | |
| Abridged model | 31/12/2016 | 03/08/2017 | 03/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 09/05/2016 | 01/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 11/05/2015 | 09/06/2015 | Dutch | |
| Abridged model | 31/12/2013 | 02/06/2014 | 02/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 03/06/2013 | 02/07/2013 | Dutch | |
| Abridged model | 31/12/2011 | 12/06/2012 | 06/07/2012 | Dutch | |
| Abridged model | 31/12/2010 | 14/06/2011 | 12/07/2011 | Dutch | |
| Abridged model | 31/12/2009 | 07/06/2010 | 07/07/2010 | Dutch | |
| Abridged model | 31/12/2008 | 21/08/2009 | 01/09/2009 | Dutch | |
| Abridged model | 31/12/2007 | 21/08/2008 | 25/08/2008 | Dutch | |
| Abridged model | 31/12/2006 | 14/05/2007 | 02/08/2007 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 2 active · 9 ended
Active mandates
Active
Pieter Vermeersch
ActiveShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Other31/12/2024BENAMING, STATUTEN (VERTALING, COORDINATIE, OVERIGE
- Mandates22/10/2024Ontslag en benoeming bestuurder
- Mandates28/12/2023WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
- Mandates06/03/2009ONTSLAGEN - BENOEMINGEN
- Capital / shares28/10/2005ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202554 k €↑
- 2024Annual accounts 202445,5 k €↓
- 2024Name changeAalst Pharma
- 2023Annual accounts 2023155,4 k €↑
- 2022Annual accounts 2022143,6 k €↑
- 2021Annual accounts 2021111,7 k €↑
- 2018Annual accounts 201837,9 k €↓
- 2017Annual accounts 201743 k €↓
- 2016Annual accounts 201651,8 k €↑
- 2015Annual accounts 201535,6 k €↓
- 2014Annual accounts 201456,2 k €↓
- 2013Annual accounts 201362,2 k €↑
- 2012Annual accounts 201248,4 k €↓
- 2011Annual accounts 201173,5 k €↑
- 2010Annual accounts 201064,5 k €↓
- 2009Annual accounts 200967,7 k €↑
- 2008Annual accounts 2008-51,5 k €↓
- 2007Annual accounts 2007-27,4 k €↓
- 2006Annual accounts 20067,1 k €
- 2006Name changeImmopharma
- 19/07/1991IncorporationPrivate limited company